Used in pharmaceutical research as an intermediate in the synthesis of nucleoside analogs, particularly for antiviral and anticancer agents. Its brominated purine base allows for further chemical modifications, enabling the development of biologically active compounds. The acetyl-protected sugar moiety enhances solubility and stability during synthetic processes, making it valuable in controlled nucleoside assembly. This protected form of 8-bromo-2'-deoxyguanosine facilitates selective reactions in nucleoside chemistry.